Literature DB >> 31442075

Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients With Impaired Cognitive Function.

Moo-Nyun Jin1, Tae-Hoon Kim1, Ki-Woon Kang2, Hee Tae Yu1, Jae-Sun Uhm1, Boyoung Joung1, Moon-Hyoung Lee1, Eosu Kim3, Hui-Nam Pak1.   

Abstract

BACKGROUND: Although atrial fibrillation (AF) has a risk of cognitive dysfunction, it is not clear whether AF catheter ablation improves or worsens cognitive function. This prospective case-control study sought to assess the 1-year serial changes in the cognitive function with or without AF catheter ablation.
METHODS: We evaluated the Montreal Cognitive Assessment score in 308 patients (71.4% male, 60.6±9.1 years of age, 34.1% persistent AF) who underwent AF ablation (ablation group) and 50 AF patients on medical therapy who met the same indication for AF ablation (control group), at baseline and 3 and 12 months after enrollment. Cognitive impairment was defined as a published cutoff score of <23 points. To exclude any learning effects, we used the practice-adjusted reliable change index for assessing the cognitive changes.
RESULTS: Preablation cognitive impairment was detected in 18.5% (57/308). The Montreal Cognitive Assessment score significantly improved 1 year after radiofrequency catheter ablation in both overall ablation group (24.9±2.9-26.4±2.5; P<0.001) and the propensity-matched ablation group (25.4±2.4-26.5±2.3; P<0.001), but not in the control group (25.4±2.5-24.8±2.5; P=0.012). Preablation cognitive impairment (odds ratio, 13.70; 95% CI, 4.83-38.87; P<0.001) was independently associated with an improvement in the 1-year post-ablation cognitive function. In the reliable change index analyses, 94.7% of propensity-matched ablation group showed an improved/stable cognitive function at the 1-year follow-up.
CONCLUSIONS: Catheter ablation of AF, at least, does not deteriorate the cognitive function, but rather improves the performance on 1-year follow-up neurocognitive tests, especially in patients with a preablation cognitive impairment.

Entities:  

Keywords:  atrial fibrillation; brain infarction; catheter ablation; cognitive function; dementia

Mesh:

Year:  2019        PMID: 31442075     DOI: 10.1161/CIRCEP.119.007197

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  24 in total

1.  Catheter Ablation and Cognitive Impairment in Atrial Fibrillation: Another Hit or a Silver Bullet?

Authors:  Lindsey Rosman; Matthew M Burg; Rachel Lampert
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-07-01

2.  Thromboembolism and bleeding risk in atrial fibrillation ablation with uninterrupted anticoagulation between new oral anticoagulants and vitamin K antagonists: insights from an updated meta-analysis.

Authors:  Xiao-Hua Liu; Xiao-Fei Gao; Chao-Feng Chen; Bin Chen; Yi-Zhou Xu
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

3.  Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation.

Authors:  Youzheng Dong; Zhenyu Zhai; Bo Zhu; Shucai Xiao; Yang Chen; Anxue Hou; Pengtao Zou; Zirong Xia; Jianhua Yu; Juxiang Li
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-22       Impact factor: 3.727

4.  The effects of family follow-up nursing on elderly cognitive impairment patients' Barthel index scores and mental statuses.

Authors:  Wei Lu; Qinghua Mao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 5.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

6.  Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype.

Authors:  Inseok Hwang; Je-Wook Park; Oh-Seok Kwon; Byounghyun Lim; Myunghee Hong; Min Kim; Hee-Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

7.  Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation.

Authors:  Hee Tae Yu; In-Soo Kim; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  J Cardiovasc Electrophysiol       Date:  2020-01-15

8.  Prevalence and Progression of Cognitive Impairment in Atrial Fibrillation Patients after Treatment with Catheter Ablation or Drug Therapy.

Authors:  Tina S Tischer; Daniel Nitschke; Isabelle Krause; Günther Kundt; Alper Öner; Giuseppe D'Ancona; Erdal Şafak; Hüseyin Ince; Jasmin Ortak; Evren Caglayan
Journal:  Cardiol Res Pract       Date:  2019-12-14       Impact factor: 1.866

9.  Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation.

Authors:  Nguyen Khac Le Son; Je Wook Park; Min Kim; Song Yi Yang; Hee Tae Yu; Tae Hoon Kim; Jae Sun Uhm; Boyoung Joung; Moon Hyoung Lee; Hui Nam Pak
Journal:  Korean Circ J       Date:  2020-03-12       Impact factor: 3.243

10.  Five-Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation.

Authors:  Je-Wook Park; Pil-Sung Yang; Han-Joon Bae; Song-Yi Yang; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  J Am Heart Assoc       Date:  2019-08-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.